申请人:UNIVERSITÉ DE STRASBOURG
公开号:US20190328887A1
公开(公告)日:2019-10-31
The present invention relates to metabolically stable and non-immunogen analogs completely hydrosolubleat physiological pH, and their use for the prevention or treatment of diseases mediated by G-protein coupled receptor (GPCR), in particular (Central Nervous System) CNS and cardiovascular diseases or disorders, or their use in diagnostic methods.